Embed Size (px)
Citation preview
Philadelphia SensiQuantRare Variants
Detection and quantification of t(9;22) BCR-ABL mRNA Rare Variants
M-bcr: e14a3 (b3a3) e13a3 (b2a3)m-bcr: e1a3u-bcr(p230): e19a2 e19a3
One-Step REAL TIME PCR
High Diagnostic and Analytical sensitivity
Quantitative standard aligned to ERM plasmid solutions
Primers and probes suitable for Digital Droplet PCR (ddPCR) analysis
5 points Standard Set 10^5-10^1 copies/react
Philadelphia SensiQuant
Rare Variants Kits
A sensitive and effective method for the monitoring of minimal residual disease
in CML patients and for the detection and quantification of the rare variants of
BCR-ABL fusion genes.
Product Description Ref. Format
SensiQuant b3a3/b2a3 Master Mix
One-Step PCR Master Mix
SQT-042 2 x 48 test
SensiQuant e1a3 MasterMix
One-Step PCR Master Mix
SQT-041 2 x 48 test
SensiQuant P230 (m-BCR) sterMix
One-Step PCR Master Mix
SQT-040 2 x 48 test
SensiQuant b3a3/b2a3 Standard
Quantitative Standard
STD-042 4 runs
SensiQuant e1a3 Standard
Quantitative Standard
STD-041 4 runs
SensiQuant 230 (m-BCR) Standard
Quantitative Standard
STD-040 4 runs
SensiQuant RARE VARIANTS PRODUCTS and ACCESSORIES
Bioclarma srlOperations : Via Nizza, 52 - 10126 TORINO
Legal Office: Via Morgari, 23 - 10125 TORINO - VAT IT09506040014Tel. +39-011-670-64-46Fax +39-011-670-84-16
E-mail [email protected]: www.bioclarma.com
YK
I 004-0
10 E
NG
